Human (cid:1) Defensin in HIV-Exposed But Uninfected Individuals
暂无分享,去创建一个
M. Clerici | M. Biasin | F. Mazzotta | P. Ferrante | M. Saresella | M. Franchini | D. Trabattoni | S. Caputo | G. Maffeis | F. Vichi | P. Pierotti | F. Fasano
[1] D. Scott‐Algara,et al. CD4 cell and CD8 cell-mediated resistance to HIV-1 infection in exposed uninfected intravascular drug users in Vietnam , 2003, AIDS.
[2] John P. Moore. Faculty Opinions recommendation of CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition. , 2003 .
[3] Annapurna Vyakarnam,et al. Presence of HIV-1 Gag-Specific IFN-γ+IL-2+ and CD28+IL-2+ CD4 T Cell Responses Is Associated with Nonprogression in HIV-1 Infection1 , 2002, The Journal of Immunology.
[4] C. Hallahan,et al. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors , 2002, Nature Immunology.
[5] B. Gazzard,et al. A Balanced Type 1/Type 2 Response Is Associated with Long-Term Nonprogressive Human Immunodeficiency Virus Type 1 Infection , 2002, Journal of Virology.
[6] J. Levy,et al. Relationship of CD8(+) T cell noncytotoxic anti-HIV response to CD4(+) T cell number in untreated asymptomatic HIV-infected individuals. , 2002, Blood.
[7] E. Dalmasso,et al. Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. , 2002, Science.
[8] K. Fellermann,et al. Defensins – innate immunity at the epithelial frontier , 2001, European journal of gastroenterology & hepatology.
[9] R. Brookmeyer,et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda , 2001, The Lancet.
[10] S. Steinberg,et al. Generation of alloantigen-stimulated anti-human immunodeficiency virus activity is associated with HLA-A*02 expression. , 2001, The Journal of infectious diseases.
[11] M. Luscher,et al. Sequence and peptide-binding motif for a variant of HLA-A*0214 (A*02142) in an HIV-1-resistant individual from the Nairobi Sex Worker cohort , 2001, Immunogenetics.
[12] K. Conant,et al. The role of chemokines in human immunodeficiency virus infection , 2000, Immunological reviews.
[13] S. Rowland-Jones,et al. Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. , 2000, The Journal of infectious diseases.
[14] K. Rabe,et al. Defensins: key players or bystanders in infection, injury, and repair in the lung? , 1999, The Journal of allergy and clinical immunology.
[15] D. Cooper,et al. CD8+ anti-human immunodeficiency virus suppressor activity (CASA) in response to antiretroviral therapy: loss of CASA is associated with loss of viremia. , 1999, The Journal of infectious diseases.
[16] P. Vernazza,et al. Sexual transmission of HIV: infectiousness and prevention. , 1999, AIDS.
[17] J. Skurnick,et al. Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[18] R. Kaul,et al. HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. , 1999, AIDS.
[19] J. Phair,et al. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation , 1998, Nature Medicine.
[20] Luc Montagnier,et al. HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene , 1998, The Lancet.
[21] M. Robb,et al. Epidemiologic and Biologic Characterization of a Cohort of Human Immunodeficiency Virus Type 1 Highly Exposed, Persistently Seronegative Female Sex Workers in Northern Thailand , 1998 .
[22] R. Koup,et al. Genetic and immunological host factors associated with susceptibility to HIV-1 infection. , 1998, AIDS.
[23] M. Clerici,et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals , 1997, Nature Medicine.
[24] C. Janeway,et al. Innate Immunity: The Virtues of a Nonclonal System of Recognition , 1997, Cell.
[25] Richard A Koup,et al. Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.
[26] J. Levy,et al. Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. , 1996, Immunology today.
[27] Steven M. Wolinsky,et al. Relative resistance to HIV–1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high–risk sexual exposures , 1996, Nature Medicine.
[28] M. Clerici,et al. Protective immunity against HIV infection: has nature done the experiment for us? , 1996, Immunology today.
[29] R. Ahmed,et al. Immunity to infection. , 1998, Current opinion in immunology.
[30] S. Rowland-Jones,et al. Immune responses in HIV-exposed seronegatives: have they repelled the virus? , 1995, Current opinion in immunology.
[31] J. Berzofsky,et al. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. , 1995, The Journal of clinical investigation.
[32] J. Berzofsky,et al. HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood. , 1994, JAMA.
[33] J. Berzofsky,et al. Cellular immune factors associated with mother‐to-infant transmission of HIV , 1993, AIDS.
[34] T. Ganz,et al. Isolation and characterization of human defensin cDNA clones. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[35] T. Ganz,et al. DEFENSINS: NATURAL PEPTIDE ANTIBIOTICS IN HUMAN NEUTROPHILS , 1986 .